176 related articles for article (PubMed ID: 36716083)
1. Identification of Cell-Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis.
Adams C; Nair N; Plant D; Verstappen SMM; Quach HL; Quach DL; Carvidi A; Nititham J; Nakamura M; Graf J; Barton A; Criswell LA; Barcellos LF
Arthritis Rheumatol; 2023 Jul; 75(7):1088-1097. PubMed ID: 36716083
[TBL] [Abstract][Full Text] [Related]
2. Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis.
Nair N; Plant D; Verstappen SM; Isaacs JD; Morgan AW; Hyrich KL; Barton A; Wilson AG;
Rheumatology (Oxford); 2020 Jun; 59(6):1364-1371. PubMed ID: 31598719
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action.
Guderud K; Sunde LH; Flåm ST; Mæhlen MT; Mjaavatten MD; Norli ES; Evenrød IM; Andreassen BK; Franzenburg S; Franke A; Rayner S; Gervin K; Lie BA
Front Immunol; 2021; 12():713611. PubMed ID: 34867944
[TBL] [Abstract][Full Text] [Related]
4. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
[TBL] [Abstract][Full Text] [Related]
5. Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Plant D; Maciejewski M; Smith S; Nair N; ; Hyrich K; Ziemek D; Barton A; Verstappen S
Arthritis Rheumatol; 2019 May; 71(5):678-684. PubMed ID: 30615300
[TBL] [Abstract][Full Text] [Related]
6. Adenosine Deaminase Gene Polymorphism and Baseline Serum Level of Adenosine Deaminase as a Biomarker of Response to Methotrexate in Rheumatoid Arthritis.
Gangadharan H; Singh A; Majumder S; Aggarwal A
J Clin Rheumatol; 2021 Dec; 27(8):e609-e611. PubMed ID: 33044386
[TBL] [Abstract][Full Text] [Related]
7. Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients.
Gosselt HR; Vallerga CL; Mandaviya PR; Lubberts E; Hazes JMW; de Jonge R; Heil SG
PLoS One; 2021; 16(3):e0247709. PubMed ID: 33690661
[TBL] [Abstract][Full Text] [Related]
8. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4
Guderud K; Sunde LH; Flåm ST; Mæhlen MT; Mjaavatten MD; Lillegraven S; Aga AB; Evenrød IM; Norli ES; Andreassen BK; Franzenburg S; Franke A; Haavardsholm EA; Rayner S; Gervin K; Lie BA
Front Immunol; 2020; 11():194. PubMed ID: 32117312
[No Abstract] [Full Text] [Related]
10. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.
Oliveira RD; Fontana V; Junta CM; Marques MM; Macedo C; Rassi DM; Passos GA; Donadi EA; Louzada-Junior P
J Rheumatol; 2012 Aug; 39(8):1524-32. PubMed ID: 22753658
[TBL] [Abstract][Full Text] [Related]
11. Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients.
Gosselt HR; van Zelst BD; de Rotte MCFJ; Hazes JMW; de Jonge R; Heil SG
Arthritis Res Ther; 2019 Jun; 21(1):157. PubMed ID: 31242943
[TBL] [Abstract][Full Text] [Related]
12. Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
Palmowski A; Strehl C; Pfeiffenberger M; Häupl T; Schad M; Kallarackal J; Prothmann U; Dammann D; Bonin M; Brandt A; Schneider U; Gaber T; Buttgereit F
Clin Rheumatol; 2024 Jan; 43(1):511-519. PubMed ID: 37978145
[TBL] [Abstract][Full Text] [Related]
13. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
14. Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis.
Muto S; Minamitani N; Ogura T; Nakajima A; Nakagawa K; Masaka T; Hiura S; Kobayashi H; Kato H; Kameda H
Mod Rheumatol; 2021 Nov; 31(6):1079-1086. PubMed ID: 33492182
[TBL] [Abstract][Full Text] [Related]
15. Seropositivity-Dependent Association between LINE-1 Methylation and Response to Methotrexate Therapy in Early Rheumatoid Arthritis Patients.
Ravaei A; Pulsatelli L; Assirelli E; Meliconi R; Ciaffi J; Gremese E; Tolusso B; Salvarani C; Govoni M; Rubini M
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360249
[TBL] [Abstract][Full Text] [Related]
16. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients.
Tan W; Wang F; Guo D; Ke Y; Shen Y; Lv C; Zhang M
Int J Rheum Dis; 2016 May; 19(5):482-9. PubMed ID: 24863583
[TBL] [Abstract][Full Text] [Related]
17. Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial.
Sode J; Krintel SB; Carlsen AL; Hetland ML; Johansen JS; Hørslev-Petersen K; Stengaard-Pedersen K; Ellingsen T; Burton M; Junker P; Østergaard M; Heegaard NHH
J Rheumatol; 2018 Jan; 45(1):53-61. PubMed ID: 29142030
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
